Periodic Reporting for period 1 - SIMCARE (SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment)
Reporting period: 2019-06-01 to 2019-11-30
The objective of the feasibility study was to understand the technical and commercial requirements to bring GoSmart to market within the next 3 years.
The commercial feasibility included an assessment of the regulatory environment for hosting patient data on the cloud and marketing GoSmart for clinical use through CE marking in Europe and FDA approval in the US. We also exhibited at a radiology medical conference and presented the software to a range of potential customers.
The SIMCARE project has increased our exposure to the medical community and has provided us with the technical and commercial information needed to plan the commercialisation of GoSmart as both a training and clinical tool over the next 1-3 years.